advertisement
Wu Y 18
Showing records 1 to 18 | Display all abstracts from Wu Y92310 Antiglaucoma Potential of β-Glucogallin Is Mediated by Modulating Mitochondrial Responses in Experimentally Induced Glaucoma
Cao T
Neuroimmunomodulation 2021; 0: 1-10
92366 Somatic GNAQ R183Q mutation is located within the sclera and episclera in patients with Sturge-Weber syndrome
Wu Y
British Journal of Ophthalmology 2022; 106: 1006-1011
92093 Comparison of conbercept and ranibizumab combined mitomycin C-augmented trabeculectomy for neovascular glaucoma
Guo X
International Ophthalmology 2021; 41: 2869-2877
92310 Antiglaucoma Potential of β-Glucogallin Is Mediated by Modulating Mitochondrial Responses in Experimentally Induced Glaucoma
Wang J
Neuroimmunomodulation 2021; 0: 1-10
92093 Comparison of conbercept and ranibizumab combined mitomycin C-augmented trabeculectomy for neovascular glaucoma
Wang Y
International Ophthalmology 2021; 41: 2869-2877
92366 Somatic GNAQ R183Q mutation is located within the sclera and episclera in patients with Sturge-Weber syndrome
Peng C; Huang L
British Journal of Ophthalmology 2022; 106: 1006-1011
92310 Antiglaucoma Potential of β-Glucogallin Is Mediated by Modulating Mitochondrial Responses in Experimentally Induced Glaucoma
Wu Y
Neuroimmunomodulation 2021; 0: 1-10
92093 Comparison of conbercept and ranibizumab combined mitomycin C-augmented trabeculectomy for neovascular glaucoma
Yang L
International Ophthalmology 2021; 41: 2869-2877
92366 Somatic GNAQ R183Q mutation is located within the sclera and episclera in patients with Sturge-Weber syndrome
Xu L
British Journal of Ophthalmology 2022; 106: 1006-1011
92093 Comparison of conbercept and ranibizumab combined mitomycin C-augmented trabeculectomy for neovascular glaucoma
Wang P
International Ophthalmology 2021; 41: 2869-2877
92310 Antiglaucoma Potential of β-Glucogallin Is Mediated by Modulating Mitochondrial Responses in Experimentally Induced Glaucoma
Wang L; Zhang H
Neuroimmunomodulation 2021; 0: 1-10
92366 Somatic GNAQ R183Q mutation is located within the sclera and episclera in patients with Sturge-Weber syndrome
Ding X
British Journal of Ophthalmology 2022; 106: 1006-1011
92093 Comparison of conbercept and ranibizumab combined mitomycin C-augmented trabeculectomy for neovascular glaucoma
Chen K
International Ophthalmology 2021; 41: 2869-2877
92366 Somatic GNAQ R183Q mutation is located within the sclera and episclera in patients with Sturge-Weber syndrome
Liu Y
British Journal of Ophthalmology 2022; 106: 1006-1011
92093 Comparison of conbercept and ranibizumab combined mitomycin C-augmented trabeculectomy for neovascular glaucoma
Zhou L
International Ophthalmology 2021; 41: 2869-2877
92366 Somatic GNAQ R183Q mutation is located within the sclera and episclera in patients with Sturge-Weber syndrome
Zeng C
British Journal of Ophthalmology 2022; 106: 1006-1011
92093 Comparison of conbercept and ranibizumab combined mitomycin C-augmented trabeculectomy for neovascular glaucoma
Wu Y
International Ophthalmology 2021; 41: 2869-2877
92366 Somatic GNAQ R183Q mutation is located within the sclera and episclera in patients with Sturge-Weber syndrome
Sun H; Guo W
British Journal of Ophthalmology 2022; 106: 1006-1011
